Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter.
about
An orthotopic bladder cancer model for gene delivery studies.Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF.A Murine Orthotopic Bladder Tumor Model and Tumor Detection System.Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer.
P2860
Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Monitoring the response of ort ...... ic antigen gene as a reporter.
@en
type
label
Monitoring the response of ort ...... ic antigen gene as a reporter.
@en
prefLabel
Monitoring the response of ort ...... ic antigen gene as a reporter.
@en
P2093
P1476
Monitoring the response of ort ...... ic antigen gene as a reporter.
@en
P2093
Kesavan Esuvaranathan
Qinghui Wu
Ratha Mahendran
P304
P356
10.1158/1078-0432.CCR-04-0605
P407
P577
2004-10-01T00:00:00Z